The purpose of this study is to learn more about how well the COVID-19 vaccine works for patients with IBD. This includes people with Crohn's disease and ulcerative colitis. We want to learn more about side effects, and whether the vaccine impacts IBD activity. This study does not provide the COVID-19 vaccine and is only for people who have already received at least 1 vaccine.
There will be 8 surveys for you to take over the course of the study. In these surveys, we will ask you some questions about yourself, your IBD, and your IBD medications. We will also ask you to provide some information about your COVID-19 vaccine, including any side effects you may have experienced. You will have the option to complete 2 blood draws to check your antibody response to the vaccine, these results will be returned to you after each blood draw.
Up to $130 if you complete all aspects of the study
100% Remote (online, phone, text)
Kimberly Weaver
Pediatrics - Gastroenterology
Clinical or Medical
Observational
Chronic Conditions
Stomach, Digestion and Gut Health
Immune System/Infections
COVID-19
21-0301
Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?